A Randomized, Double-blind, Placebo Controlled Trial of 4-Hydroxytamoxifen Gel for Reducing Breast Tissue Density in Women With BI-RADS Breast Density Categories C or D
Phase of Trial: Phase III
Latest Information Update: 20 Apr 2018
At a glance
- Drugs Afimoxifene (Primary)
- Indications Hyperplasia
- Focus Registrational; Therapeutic Use
- Acronyms 4WARD
- Sponsors BHR Pharma
- 24 Aug 2017 Status changed from not yet recruiting to recruiting.
- 11 Jul 2017 Planned initiation date changed from 30 Jun 2017 to 30 Jul 2017.
- 29 Jun 2017 New trial record